Core Laboratories N.V.
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 470.25M | 489.74M | 509.79M | 523.85M | 526.52M | 0.5% | |
| Cost of Revenue | (386.41M) | (410.82M) | (415.74M) | (435.48M) | (432.24M) | -0.7% | |
Gross Profit | 83.84M | 78.92M | 94.05M | 88.37M | 94.28M | 6.7% | |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | |
| Selling, General & Administrative | (44.17M) | (38.12M) | (38.89M) | (38.59M) | (44.23M) | 14.6% | |
| General & Administrative | (44.17M) | (38.12M) | (40.26M) | (38.59M) | (44.23M) | 14.6% | |
| Depreciation & Amortization | (18.52M) | (17.16M) | (15.78M) | (14.95M) | (14.65M) | -2.0% | |
Operating Income (EBIT) | 45.26M | 41.52M | 54.64M | 58.56M | 50.49M | -13.8% | |
| Non-Operating Items | |||||||
| Interest Income | — | — | — | — | — | — | |
| Interest Expense | (9.15M) | (11.57M) | (13.43M) | (12.37M) | (10.57M) | -14.5% | |
| Other Income/Expenses (Net) | -9.15M | -11.57M | -13.43M | -12.37M | -4.59M | -62.9% | |
Income Before Tax | 36.11M | 29.95M | 41.21M | 46.19M | 45.90M | -0.6% | |
| Income Tax Expense | (15.89M) | (10.30M) | (4.18M) | (14.03M) | (15.51M) | 10.5% | |
Net Income | 19.73M | 19.45M | 36.67M | 31.40M | 29.67M | -5.5% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $0 | $0 | $1 | $1 | $1 | 1.5% | |
| Weighted Avg Shares Outstanding | 46.01M | 46.33M | 46.68M | 46.90M | 46.50M | -0.8% | |
| Weighted Avg Shares Outstanding (Diluted) | 46.69M | 46.81M | 47.52M | 47.69M | 46.50M | -2.5% | |
EBITDA | 63.78M | 58.69M | 70.42M | 73.51M | 71.12M | -3.3% |
Explore CLB
CLB in the Energy
Small Cap